Duke Inventions Bring $82.6M in Revenue and Launch 6 New Start-Ups
Read More

Sparta Biomedical Reports Treatment of First Patients with Breakthrough Device, Ormi
Read More

Basking Biosciences Doses First Patients in Phase 2 Clinical Trial of Reversible Thrombolytic BB-031 for Acute Ischemic Stroke
Read More

Adaptin Bio Announces FDA Clearance of IND Application for APTN-101 in Glioblastoma
Read More

Lindy Biosciences Enters Licensing and Collaboration Agreement With Novartis for Multi-target Drug Delivery Innovation
Read More

From Interns to Employees: Duke Trainees Find Full-Time Home at OTC
Read More

Carpe, a Duke-founded Startup, Acquired by Topspin Consumer Partners
Read More

New therapy for glioma receives FDA approval, leveraging cancer research conducted at Johns Hopkins & Duke University
Read More

The Kardashians Take Longevity Test that Reveals Biological Age in 'The Kardashians' Upcoming Season Finale
Read More

Media Coverage: WRAL TechWire October 25, 2021

Featuring OTC FY21 Annual Report

Have Questions?

Please contact us or subscribe for more opportunities